The country of Georgia initiated an ambitious national hepatitis C elimination program. To facilitate elimination, a national hospital hepatitis C screening program was launched in November 2016, offering all inpatients screening for HCV infection. This analysis assesses the effectiveness of the first year of the screening program to identify HCV-infected persons and link them to care. Data from Georgia's electronic Health Management Information System and ELIMINATION-C treatment database were analyzed for patients aged 6518\ua0years hospitalized from November 1, 2016 to October 31, 2017. We described patient characteristics and screening results and compared linked-to-care patients to those not linked to care, defined as having a test for...
Background.Mortality related to hepatitis C virus (HCV) infection is a key indicator for elimination...
Background/Aims: With increased national focus on diagnosing and linking patients to care or treatme...
With recommended screening for hepatitis C among the 1945-1965 birth cohort and advent of novel high...
Background & AimsGeorgia, with a high prevalence of HCV infection, launched the world\u2019s first n...
BackgroundThe country of Georgia launched the world\u2019s first Hepatitis C Virus (HCV) Elimination...
Hepatitis C is a common blood borne infection in the United States; currently this infection is a pr...
Abstract Background The country of Georgia launched the world’s first Hepatitis C Virus (HCV) Elimin...
Background: In this brief report, we discuss enhancing access to hepatitis C treatment for uninsured...
In April 2015, the country of Georgia, with a high prevalence of hepatitis C virus (HCV) infection (...
Background: Chronic hepatitis C virus (HCV) affects more than 3 million people in the United States....
With recommended screening for hepatitis C among the 1945-1965 birth cohort and advent of novel high...
Highly efficacious and tolerable treatments that cure hepatitis C viral (HCV) infection exist today,...
Highly efficacious and tolerable treatments that cure hepatitis C viral (HCV) infection exist today,...
OBJECTIVES: Effective screening, diagnosis, and treatment are needed to reduce chronic hepatitis C v...
With recommended screening for hepatitis C among the 1945-1965 birth cohort and advent of novel high...
Background.Mortality related to hepatitis C virus (HCV) infection is a key indicator for elimination...
Background/Aims: With increased national focus on diagnosing and linking patients to care or treatme...
With recommended screening for hepatitis C among the 1945-1965 birth cohort and advent of novel high...
Background & AimsGeorgia, with a high prevalence of HCV infection, launched the world\u2019s first n...
BackgroundThe country of Georgia launched the world\u2019s first Hepatitis C Virus (HCV) Elimination...
Hepatitis C is a common blood borne infection in the United States; currently this infection is a pr...
Abstract Background The country of Georgia launched the world’s first Hepatitis C Virus (HCV) Elimin...
Background: In this brief report, we discuss enhancing access to hepatitis C treatment for uninsured...
In April 2015, the country of Georgia, with a high prevalence of hepatitis C virus (HCV) infection (...
Background: Chronic hepatitis C virus (HCV) affects more than 3 million people in the United States....
With recommended screening for hepatitis C among the 1945-1965 birth cohort and advent of novel high...
Highly efficacious and tolerable treatments that cure hepatitis C viral (HCV) infection exist today,...
Highly efficacious and tolerable treatments that cure hepatitis C viral (HCV) infection exist today,...
OBJECTIVES: Effective screening, diagnosis, and treatment are needed to reduce chronic hepatitis C v...
With recommended screening for hepatitis C among the 1945-1965 birth cohort and advent of novel high...
Background.Mortality related to hepatitis C virus (HCV) infection is a key indicator for elimination...
Background/Aims: With increased national focus on diagnosing and linking patients to care or treatme...
With recommended screening for hepatitis C among the 1945-1965 birth cohort and advent of novel high...